Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms - Tibes, Raoul; Kosiorek, Heidi E.; Dueck, Amylou C.; Palmer, Jeanne; Sproat, Lisa; Bogenberger, James; Hashmi, Shahrukh; Mesa, Ruben; Hogan, William; Litzow, Mark R.; Al‐Kali, Aref (Cancer, 2023)
Keywords: Acute myeloid leukemia; AML; azacitidine; Chronic myelomonocytic leukemia; Constipation; Cough; Diarrhea; hedgehog inhibitor; Hedgehog protein; Inhibitors; Insomnia; Leukemia; Malignancy; MDS; Myelodysplastic syndrome; Myelodysplastic syndromes; Myelofibrosis; Neoplasms; Oncology; Patients; Remission; Side effects; Sleep disorders; sonidegib; Stem cells; Survival; Tumors; AML; hedgehog inhibitor; sonidegib; MDS; azacitidine